Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,342
Closed -$764K 355
2025
Q4
$764K Buy
3,342
+1,805
+117% +$411K 0.15% 204
2025
Q3
$356K Sell
1,537
-21,960
-93% -$4.47M 0.06% 266
2025
Q2
$4.36M Buy
23,497
+19,684
+516% +$3.66M 0.91% 19
2025
Q1
$799K Buy
+3,813
New +$741K 0.24% 145
2024
Q3
Sell
-8,329
Closed -$1.43M 274
2024
Q2
$1.43M Buy
8,329
+3,173
+62% +$526K 0.64% 39
2024
Q1
$939K Sell
5,156
-6,177
-55% -$1.06M 0.49% 70
2023
Q4
$1.76M Buy
+11,333
New +$1.65M 1.13% 5
2023
Q3
Sell
-7,436
Closed -$1M 249
2023
Q2
$1M Buy
7,436
+7,024
+1,705% +$1.03M 0.57% 53
2023
Q1
$65.7K Sell
412
-988
-71% -$151K 0.06% 303
2022
Q4
$226K Buy
+1,400
New +$215K 0.42% 118
2022
Q3
Sell
-1,400
Closed -$214K 137
2022
Q2
$214K Sell
1,400
-1,577
-53% -$241K 0.48% 110
2022
Q1
$483K Buy
+2,977
New +$432K 1.06% 23
2020
Q1
Sell
-13,123
Closed -$1.16M 1
2019
Q4
$1.16M Buy
+13,123
New +$1.09M 0.46% 60
2019
Q2
Sell
-13,270
Closed -$1.07M 484
2019
Q1
$1.07M Buy
13,270
+2,878
+28% +$235K 0.42% 86
2018
Q4
$958K Buy
+10,392
New +$914K 0.63% 50

Other funds holding ABBV

Machina Capital's ABBV Position: Q1 2026 in Review

Machina Capital sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 3,342 shares — an estimated $764K sold.

Machina Capital first reported a position in ABBV in Q4 2018 and held it in 15 quarters. The position peaked at $4.36M in Q2 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Machina Capital reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Machina Capital sold 3,342 AbbVie shares in Q1 2026, an estimated $764K.
  • Machina Capital first reported a position in AbbVie in Q4 2018 and held it in 15 quarters.
  • Machina Capital's AbbVie position peaked at $4.36M in Q2 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Machina Capital's 13F filing for Q1 2026, filed 13 May 2026.